Adial Pharmaceuticals
ADIL
#10837
Rank
A$20.03 M
Marketcap
A$7.63
Share price
36.12%
Change (1 day)
1,542.46%
Change (1 year)

EPS for Adial Pharmaceuticals (ADIL)

EPS in 2026 (TTM): A-$28.45

According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$29.22. In 2025 the company made an earnings per share (EPS) of A-$18.02 an increase over its 2024 EPS that were of A-$102.75.

EPS history for Adial Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$28.4557.82%
2025A-$18.02-82.46%
2024A-$102.75-24.43%
2023A-$135.97-71.68%
2022A-$480.06-51.12%
2021A-$982.0219.54%
2020A-$821.50-0%
2019A-$821.50-64.34%
2018A-$2,3041072.27%
2017A-$196.54136.68%
2016A-$83.04-56.33%
2015A-$190.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.09065-99.69% Bahamas
NRC Health
NRC
A$0.44-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA